Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-12, with 10 holding rows worth $120,705,624.

Accession
0000902664-24-001422
Filed
2024-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 10 entries on the cover page, a total value of $120,705,624 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,705,624 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,373,413$37,235,736dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$36,438,105dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM523,280$15,682,702dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS363,800$6,319,206dollars as filed
CURIS INC231269309COM421,951$5,379,875dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM142,800$5,212,200dollars as filed
BRIDGEBIO PHARMA INC10806X102COM121,200$4,892,844dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,910,600$3,782,988dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock216,600$3,699,528dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$2,062,440dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-24-001422this filing2024-02-12acceptance time not in the bulk data set